Related Experiment Videos
Altered epigenetic signals in human disease
Luciano Di Croce1, M Buschbeck, A Gutierrez
1ICREA and Center for Genomic Regulation, Barcelona, Spain. luciano.dicroce@crg.es
Cancer Biology & Therapy
|October 7, 2004
Summary
Epigenetic changes like DNA and histone methylation are crucial in cancer progression. Targeting these epigenetic events offers potential new cancer therapies.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Genetic information in eukaryotic cells is stored in chromatin.
- Cancer cells frequently exhibit altered chromatin organization and epigenetic marks, including DNA and histone methylation.
- Epigenetic alterations play a significant role in human diseases.
Purpose of the Study:
- To review the role of DNA methylation, histone methylation, and chromatin alterations in human diseases.
- To highlight the cross-talk between epigenetic signals in gene silencing.
- To discuss the potential of targeting epigenetic enzymes in cancer therapy.
Main Methods:
- Utilized Acute Promyelocytic Leukemia as a model system.
- Investigated the correlation between epigenetic events and cancer progression.
- Reviewed existing literature on epigenetic modifications in human diseases.
Main Results:
- Demonstrated a direct correlation between epigenetic events induced by PML-RARalpha and cancer progression in Acute Promyelocytic Leukemia.
- Identified enzymes involved in these epigenetic events as potential therapeutic targets.
- Observed cross-talk between epigenetic signals contributing to gene silencing.
Conclusions:
- Epigenetic alterations, particularly DNA and histone methylation, are integral to cancer development and progression.
- Targeting enzymes responsible for epigenetic modifications presents a promising avenue for cancer treatment.
- Epigenetic signals interact and influence physiological and pathological gene silencing.